Chartwell Investment Partners’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
FAM
WRF
GS
CS
NCGI
O
Chartwell Investment Partners's CDNA Position: Q1 2019 in Review
Chartwell Investment Partners sold out of CareDx (CDNA) in Q1 2019, closing a stake of 37,059 shares — an estimated $932K sold.
Chartwell Investment Partners first reported a position in CDNA in Q3 2018 and held it in 2 quarters. The position peaked at $1.67M in Q3 2018. 182 funds tracked by Wall St. Rank hold CDNA as of Q1 2019.
- Chartwell Investment Partners reported no remaining CareDx position as of Q1 2019 after selling out during the quarter.
- Chartwell Investment Partners sold 37,059 CareDx shares in Q1 2019, an estimated $932K.
- Chartwell Investment Partners first reported a position in CareDx in Q3 2018 and held it in 2 quarters.
- Chartwell Investment Partners's CareDx position peaked at $1.67M in Q3 2018.
- 182 funds tracked by Wall St. Rank held CareDx as of Q1 2019.
Based on Chartwell Investment Partners's 13F filing for Q1 2019, filed 11 Apr 2019.